17th Annual CPhI Pharma Awards Winners Announced

The CPhI Awards Recognize Excellence in Pharma. The winners of the 17th annual CPhI Pharma Awards, Powered by Informa Pharma Intelligence, were announced at its first-ever virtual ceremony on 13 October 2020.
Comunicato Precedente

next
Comunicato Successivo

next

The winners of the 17th annual CPhI Pharma Awards, Powered by Informa Pharma Intelligence, were announced at its first-ever virtual ceremony on 13 October 2020. Since 2003, the CPhI Pharma Awards have recognised outstanding achievement in the pharmaceutical and biopharmaceutical industry, and this year’s digital event was no exception. Each category at the prestigious Awards ceremony celebrated the individuals, teams, and organizations committed to driving the industry forward. 

 

This year’s Awards featured fourteen categories, including – fittingly – the newly added Excellence in Pharma: Innovation in Response to COVID-19 category.

 

Tara Dougal, Head of Content at Informa commented: “This year has been a truly ground-breaking year for innovation in the pharmaceutical industry as demonstrated by the quality of the entries for the CPhI Pharma Awards covering all parts of the pharmaceutical supply chain. The judges have tirelessly worked to ensure that all award submissions and their merits were thoroughly evaluated, and I’d like to thank them for all their efforts.” 

 

The Awards were judged by an esteemed panel of industry experts from around the world, each chosen for their knowledge, objectivity and credibility.

 

Here is the complete list of winners for the 2020 CPhI Pharma Awards:

 

Category

Winner

Excellence in Pharma: Innovation in Response to COVID-19

Beximco Pharmaceuticals

Highly Commended - Ridgeback Biotherapeutics, MK-4482 – in collaboration with Merck

Excellence in Pharma: API Development

Micropore Technologies, Membrane Crystallisation

Excellence in Pharma: Finished Formulation

Lonza Capsugel, Capsugel® DBcaps®

Highly Commended  - Uriach Italy - Colpofix TE®

Excellence in Pharma: Manufacturing Technology and Equipment

FabRx, M3DIMAKER™

Excellence in Pharma: Analysis, Testing, and Quality Control

Merck, Blazar™ platform

Excellence in Pharma: Packaging

SCHOTT Pharmaceutical Systems, SCHOTT Smart Containers

Excellence in Pharma: Drug Delivery Devices

Nemera, Safe’n’Spray

Highly Commended - Ypsomed, SmartPilot™ for YpsoMate®

 

Excellence in Pharma: Digital Innovation

Novartis Pharma Schweiz, The Advanced Myelofibrosis Risk Scoring Tool

Excellence in Pharma: Supply Chain, Logistics, and Distribution

Controlant, Cold Chain as a Service (ChaaS)®

Excellence in Pharma: Contract Services and Outsourcing

Arcinova, Flowinova

Excellence in Pharma: Sustainability

Dr. Reddy's Laboratories

Excellence in Pharma: Regulatory Procedures and Compliance

Affygility Solutions, OEL Fastrac platform

Excellence in Pharma: CEO of the Year

Bobby Sheng. CEO, Bora Pharmaceuticals

 

For more coverage of the 2020 CPhI Pharma Awards, please visit: (https://awards.cphi.com/)

 

About the CPhI Pharma Awards

 

Since 2003, the CPhI Awards have been committed to recognising excellence in pharma. Hundreds of attendees from around the world, including prominent industry figures from the pharmaceutical and biopharmaceutical industry, come together for this prestigious event.

-ENDS-

 

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, South East Asia, North America, and the Middle East and Africa. Co-locating with ICSE for contract services; P-MEC for machinery, equipment & technology; InnoPack for pharmaceutical packaging; bioLIVE for biopharma; and Finished Dosage Formulation for every aspect of the finished dosage supply chain.  CPhI provides an online buyer and supplier directory at CPhI-Online.com.

 

For more information visit https://www.cphi.com

 

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organizer, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year.

 

For more information, please visit www.informamarkets.com.

The Informa Markets annual schedule of Pharmaceutical eventsnclude: CPhI & P-MEC China 2020 (16–18 December 2020 (Virtual)); CPhI & P-MEC India 2020 (28–29 January 2021 at the India Expo Mart, Greater Noida, Delhi NCR – Delhi, India); CPhI Japan (14-16 April, 2021 at the Big Sight Exhibition Centre – Tokyo, Japan); Pharmapack Europe 2021 (19-20 May, 2021 at the Paris Expo, Porte de Versailles – Paris, France); CPhI and P-MEC China 2021 (22-24 June, 2021 at SNIEC – Shanghai, China); CPhI South East Asia (4-6 August, 2021 at Challenger 2, IMPACT, Muang Thong Thani, Thailand); CPhI North America (10 August - 12 August, 2021 at Pennsylvania Convention Centre – Philadelphia, USA); CPhI, ICSE, P-MEC, FDF, InnoPack Worldwide, BioProduction (31 August – 2 September 2021 at Fiera Milano, Milan); CPhI Middle East & Africa (26-28 September, 2021 at the Riyadh International Convention & Exhibition Center, Riyadh, Saudi Arabia); CPhI Korea (11-13 August 2021), COEX – Seoul, Korea); CPhI & P-MEC India 2021 (23–25 January 2021 at the India Expo Mart, Greater Noida, Delhi NCR – Delhi, India);

 

For media enquiries, please contact:

Alex Heeley or Abdul Khalifeh

De Facto Communications

T: +44 (0) 203 735 8168

E: [email protected] / [email protected]

Per maggiori informazioni

Ufficio Stampa

Abdul Khalifeh
 Defacto (Leggi tutti i comunicati)
]
(England) United Kingdom
[email protected]
07463317575

Allegati
Slide ShowSlide Show
Non disponibili
;